Jennison Associates »

Peregrine Pharmaceuticals shares owned by Jennison Associates

Quarter-by-quarter ownership of Peregrine Pharmaceuticals (CDMO) shares owned by Jennison Associates from 13F filings

Historical chart of Jennison Associates investment in Peregrine Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Peregrine Pharmaceuticals held by Jennison Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Peregrine Pharmaceuticals by Jennison Associates

Quarter filed Position value Share count Share price at filing
2023-12-31 $658k 101k 6.50
2023-09-30 $21M 2.3M 9.44
2023-06-30 $43M 3.1M 13.97
2023-03-31 $55M 2.9M 18.76
2022-12-31 $40M 2.9M 13.77
2022-09-30 $55M 2.9M 19.12
2022-06-30 $29M 1.9M 15.26
2022-03-31 $26M 1.3M 20.37
2021-12-31 $28M 969k 29.18
2021-09-30 $23M 1.1M 21.57
2021-06-30 $21M 811k 25.65
2021-03-31 $4.1M 223k 18.23